A Phase 1 interventional study of Nexium 40 mg DR Capsules of AstraZeneca LP, USA. and Torrent's Esomeprazole Magnesium DR Capsules 40 mg in Healthy, sponsored by Torrent Pharmaceuticals Limited. Completed. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-02-11.
Sponsored by Torrent Pharmaceuticals Limited · Phase 1, Interventional, and Treatment
Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Mg DR Capsule 1×40 mg and Nexium 40 mg DR Capsule containing Esomeprazole 40 mg of AastraZeneca LP, USA. Dosing periods of studies were separated by a washout period of 5 days.
An open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose Bioequivalence Study of Esomeprazole Mg DR Capsule containing Esomeprazole Mg 40 mg [ Test Formulation, Torrent Pharmaceutical Ltd., India] Versus Nexium 40 mg DR Capsule containing Esomeprazole 40 mg [Reference Formulation, AastraZeneca LP, USA] Under administered as the contents of capsule sprinkled over apple sauce in Healthy Human Volunteers Under Fasting Condition.
Torrent Pharmaceuticals Limited is the lead sponsor of 71 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Torrent's Esomeprazole Magnesium DR Capsules 40 mg
Drug: Torrent's Esomeprazole Magnesium DR Capsules 40 mg
Nexium 40 mg DR Capsules of AstraZeneca LP, USA
Drug: Nexium 40 mg DR Capsules of AstraZeneca LP, USA.
oral, crossover
Also known as: esomeprazole magnesium delayed release capsules
oral, crossover
Also known as: esomeprazole magnesium delayed release capsules
Cmax
Pharmacokinetic Evaluation
Time frame: Pre-dose to 20 hour post dose
AUC
Pharmacokinetic Evaluation
Time frame: Pre-dose to 20 hour post dose
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Torrent Pharmaceuticals Limited